'Neglected diseases' diaporamas de présentation

Public-Private Product Development Partnerships for Global Health R&D: Issues & Challenges

Public-Private Product Development Partnerships for Global Health R&D: Issues & Challenges. Suerie Moon Giorgio Ruffolo Doctoral Fellow in Sustainability Science & Doctoral Candidate in Public Policy Center for International Development, Harvard Kennedy School of Government

529 views • 37 slides

ASEAN regional workshop on bilateral Free Trade Agreements

ASEAN regional workshop on bilateral Free Trade Agreements. Lessons from Latin american experience. Francisco Rossi. IP and access to drugs capacity building project. UNDP - International poverty centre. Brasilia. Brazil. Francisco.rossi@undp-povertycentre.org.

654 views • 33 slides

463 views • 31 slides

Objectives and accomplishments of FVBDA Wil Milhous USF College of Public Health

Objectives and accomplishments of FVBDA Wil Milhous USF College of Public Health. Key References of Academic & PPP Success

398 views • 28 slides

TACD IPR Meeting Washington Nov 1 , 2002

Alternative R&D Strategies for Drugs for Neglected Diseases: The Case & Possible Alternatives. TACD IPR Meeting Washington Nov 1 , 2002. Neglected Diseases. Chronic Crisis Enduring medical need because of the limited availability of pharmaceuticals

360 views • 25 slides

Neglected Diseases: Policy Proposals for Universities

Neglected Diseases: Policy Proposals for Universities. Basit Khan 30 Sept 2006. What is a neglected disease?. Primarily affect LMI countries Gap in attention from global R&D Shortage of safe, effective treatments. Yamey, Brit. Med. J. 2002. Operational definition of neglected diseases.

350 views • 23 slides

Presentation outline

WHO Expert Working Group on R&D and Financing January 2009 G-FINDER: Global Funding of Innovation for Neglected Diseases. Presentation outline. Background The George Institute for International Health Neglected diseases Information gap for policy-makers G-FINDER Aims and objectives

302 views • 19 slides

Michael Lin and Gloria Tavera UAEM National Conference 2010 October 9, Duke University

358 views • 19 slides

Designing Strategies for Neglected Disease Research

Designing Strategies for Neglected Disease Research. Lecture 1A Amy Kapczynski UC Berkeley Law. From MSF Campaign for Access to Essential Medicines, AccessNews (No. 18, Jan 2009). Female Life Expectancy at Birth (2006). Japan - 86. Sierra Leone - 42.

284 views • 18 slides

Access to essential medicines of the future

563 views • 17 slides

Vaccine Development and India

Vaccine Development and India. Dr. Tarit K. Mukhopadhyay Dept. of Biochemical Engineering, UCL. Historical Perspective (1980). Source: United States CDC, 2001. Historical Perspective (2000). Source: United States CDC, 2001. The Vaccine Market. Vaccine Manufacture in India. Very active

506 views • 15 slides

DNDi Update: Global Partnership Addressing Needs of Most Neglected From Research to Access

301 views • 15 slides

Tackling DDW

The role of the pharmaceutical R&D based industry in addressing diseases of the developing world (DDW).

229 views • 15 slides

Sustainability: The R&D Pipeline for Neglected Disease Vaccines

Global Vaccines 202X: Access, Equity, Ethics 2-4 May 2011 The Franklin Institute Science Museum Philadelphia, USA. Sustainability: The R&D Pipeline for Neglected Disease Vaccines. Elizabeth L. Ponder, PhD May 4, 2011. BIO Ventures for Global Health (BVGH).

340 views • 14 slides

Sustainability: The R&D Pipeline for Neglected Disease Vaccines

Global Vaccines 202X: Access, Equity, Ethics 2-4 May 2011 The Franklin Institute Science Museum Philadelphia, USA. Sustainability: The R&D Pipeline for Neglected Disease Vaccines. Elizabeth L. Ponder, PhD May 4, 2011. BIO Ventures for Global Health (BVGH).

239 views • 14 slides

UNIVERSITIES ALLIED FOR ESSENTIAL MEDICINES

UNIVERSITIES ALLIED FOR ESSENTIAL MEDICINES. That one in every six people on this globe suffers from a disease of poverty? That ten million people die each year from diseases that have available cures? That, in the time it takes to read this slide, 5 people have died from preventable causes?.

285 views • 13 slides

343 views • 13 slides

Grid-enabled drug discovery to address neglected diseases

209 views • 9 slides

Natural Resources and Hazards Initiative

128 views • 5 slides

Population Health Approach to Neglected Diseases

Disease-Centered Approach to Neglected Diseases. Population Health Approach to Neglected Diseases. Productive & Healthy Municipalities (PAHO/WHO). Community Driven Development (World Bank). Healthy Municipalities & Communities (PAHO/WHO). Health of the Indigenous

144 views • 1 slides